Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains - Molina-Infante, J; Pazos-Pacheco, C; Vinagre-Rodriguez, G (Helicobacter, 2012)
et al.